Discovery and development of small molecule therapeutics targeting protein misfolding diseases11-50 Employees
- B2B
- Growth StageExpanding market presence
- Top InvestorsThis company has received a significant amount of investment from top investors
Protego Biopharma Funding
$130M
11 round
Protego Biopharma is active in the following markets / industries: biotechnology. The company has secured funding across 1 rounds, totaling in an amount of $130M. Their most recent funding was raised on December 1, 2025.
Funding Rounds
B
$130000000